Læknablaðið - 15.09.1991, Síða 47

LÆKNABLAÐIÐ
283
induced thrombocytopenia: Confirmation of diagnosis
with in vitro methods. Blood 1975: 45: 395-401.
54. Cines DB. Kaywin P. Bina M, Tomaski A, Schreiber
AD. Heparin associated thrombocytopenia. N Eng J
Med 1980; 303: 788-95.
55. Chong BH. Pitney WR, Castaldi PA. Heparin-
induced thrombocytopenia: association of thrombotic
complications with heparin-dependent IgG antibody
that induces thromboxane synthesis and platelet
aggregation. Lancet 1982; ii: 1246- 9.
56. Lynch DM, Howe SE. Heparin-associated
thrombocylopenia: antibody binding specificity to
platelet antigens. Blood 1985; 66: 1176-81.
57. Cines DB. Tomaski A, Tannenbaum S. Immune
endothelial- cell injury in heparin-associated
thrombocytopenia. N Engl J Med 1987; 316: 581-9.
58. Bell WR, Tomasulu PA, Alving BM, Duffy
TP. Thrombocytopenia occurring during the
administration of heparin. A prospective study in 52
patients. Ann Intem Med 1976; 85: 155-60.
59. Root RK. Ryan JL. Humoral immunity and
complement. In: Mandell GL. Douglas RG, Bennett
JE, eds. Infectious Diseases, 2nd ed. New York: John
Wiley and Sons, Inc, 1985: 31-57.
60. Aster RH, George JN. Thrombocytopenia due to
enhanced platelet destruction by immunologic
mechanisms. In: Williams WJ. Beutler E, Erslev AJ,
Lichtman MA, eds. Hematology, 4th ed. New York:
McGraw-Hill, 1990: 1370-98.
61. Kappa JR. Fisher CA, Berkowitz HD. Cottrell ED,
Addonizio. Heparin-induced platelet activation in 16
surgical patients: Diagnosis and management. J Vasc
Surg 1987; 5: 101-9.
62. Chong BH, Steele R, Chesterman CN. Heparin-
induced thrombocytopenia: A study of platelet IgG
Fc receptors. Blood 1990; 76: 451a (suppl I).
63. Bymes JJ, Moake JL. Thrombotic thrombocytopenic
purpura and the hemolytic uremic syndrome:
Evolving concepts of pathogenesis and therapy. Clin
Hematol 1986; 15: 413-43.
64. Makhoul RG, Greenberg CS, McCann RL. Heparin-
associated thrombocytopenia and thrombosis: A
serious clinical problem and potential solution. J Vasc
Surg 1986; 4: 522-8.
65. Tannenbaum SH, Finko R, Cines DB. Antibody and
immunecomplexes induce tissue factor production by
human endothelial cells. J Immunol 1986; 137: 1532-
7.
66. Kelton JG, Sheridan D. Brain H, Powers PJ, Turpie
AG, Carter CJ. Clinical usefulness of testing for
a heparin dependent platelet aggregating factor
in patients with suspected heparin associated
thrombocytopenia. J Lab Clin Med 1984; 103; 606-
12.
67. Boshkov LK, Warkentin TE, Hayward C, Andrew M,
Kelton JG. Heparin-induced thrombocytopenia and
thrombosis: Clinical and laboratory studies. Blood
1990; 76; 447a (suppl 1).
68. Cole CW, Bormanis J. Ancrod: A practical altemative
to heparin. J Vasc Surg 1988; 8: 59-63.
69. Markwardt F. Prospective clinical use of hirudin as
■án anticoagulant. Biomed Progr 1990; 2: 19-23.
70. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin
for 5 days as compared with 10 days in the initial
treatment of proximal venous thrombosis. N Eng J
Med 1990; 322: 1260- 4.
71. Mohr DN, Ryu JH, Litin SC, Rosenow EC.
Recent advances in the managcment of venous
thromboembolism. Mayo Clin Proc 1988; 63: 281-
90.
72. Laster J, Elfrink R, Silver D. Reexposure to heparin
of patients with heparin-associated antibodies. J Vasc
Surg 1989; 9; 677-82.
73. Janson PA, Moake JL, Carpinito G. Aspirin prevents
heparin-induced platelet aggregation in vivo. Br J
Hematol 1983; 53: 166-8.
74. Sobel M, Adelman B, Greenfield LJ. Dextran 40
reduces heparin-mediated platelet aggregation. J Surg
Res 1986: 40: 382-7.
75. Turpie AGG. Clinical studies: Evidence for
intervention with specific antiplatelet drugs in arterial
thromboembolism. Sem Thromb Hemostas 1988; 14;
41-9.
76. Fitzgerald GA. Drug therapy: Dipyridamole. N Eng J
Med 1987; 316: 1247-57.
77. Jakubowski JA, Maraganore JM. Inhibition of
coagulation and thrombin-induced platelet activities
by a synthetic dodecapeptide modeled on the
carboxy-terminus of hirudin. Blood 1990; 75: 399-
406.
78. Teasdale SJ, Lulys VJ, Mycyk T, Baird RJ, Glynn
MF. Ancrod anticoagulation for cardiopulmonary
bypass in heparin- induced thrombocytopenia and
thrombosis. Ann Thorac Surg 1989; 48: 712-3.
79. Demers C, Ginsberg J, Brill-Edwards P, et al. Ancrod
therapy for heparin- induced thrombocytopenia (HIT).
Blood 1990; 76: 504a (suppl 1).
80. Frame JN. Mulvey KP, Phares JC, Anderson
MJ. Correction of severe heparin associated
thrombocytopenia with intravenous gammaglobulin.
Ann Int Med 1989; 111: 946-7.
81. Nand S, Robinson JA. Plasmapheresis in the
management of heparin-associated thrombocytopenia
with thrombosis. Am J Hematol 1988; 28: 204-6.
82. Bouvier JL, Lefevre P, Villain Ph, et al. Treatment of
serious heparin- induced thrombocytopenia by plasma
exchange: Report on 4 cases. Thromb Res 1988; 51:
335-6 (letter).
83. Thorp D, Canty A, Whiting J, et al. Plasma exchange
and hcparin-induced thrombocytopenia. Progr Clin
Biol Res 1990; 337: 521-2.
84. Cohen JI, Cooper MR, Greenberg CS. Streptokinase
therapy of pulmonary emboli with heparin-associated
thrombocytopenia. Arch Intem Med 1985; 135: 1725-
6.
85. Fiessingcr JN, Aiach M, Roncato M, Debure C,
Gaux JC. Critical ischemia during heparin-induced
thrombocytopenia. Treatment by intra-arterial
streptokinase. Thromb Res 1984; 33: 235-8.
86. Delagardelle C, Harf C, Dondelinger RF, et al.
Traitemet par thrombolyse locale d’une thrombose
arterielle massive par thrombopenie induite par
l’heparine. Arc Mal Coeur 1990; 83: 113-5.
87. Marder VJ, Sherry S. Thrombolytic therapy: Current
status. (First of two parts). N Engl J Med 1988; 318:
1512- 20.
88. Mardcr VJ, Sherry S. Thrombolytic therapy: Current
status. (Second of two parts). N Engl J Med 1988;
318: 1585-95.
89. Francis CW, Marder VJ, Evarts CM, Yaukoolbodi
S. Two- step warfarin therapy: prevention of
postoperative venous thrombosis without excessive
bleeding. JAMA 1983; 249: 374-8.
90. Olinger GN, Hussey CV, Olive JA, Malik MI.
Cardiopulmonary bypass for patients with previously
documented heparin-induced platelet aggregation. J
Thorac Cardiovasc Surg 1984; 87: 673-7.
91. Matsuo T, Yamada T, Chikahira Y, Kadowaki
S. Effect of aspirin on heparin induced